PDC and anemia (phenotype): Koivunen et al. suggested that PHD inhibition showed a therapeutic role in anemia, cardiac ischemia, obesity and metabolic dysfunction, and atherosclerosis by stabilizing HIF to promote glucose intake and glycolysis over oxidative metabolism35.